Titanium vs Polymer Spinal Cages for Spinal Conditions
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two types of spinal implants—titanium and polymer—to determine which is more effective for individuals undergoing spinal fusion surgery. Spinal fusion connects two or more bones in the spine, and the trial will assess how well each implant aids bone healing and overall recovery. Individuals who have tried other treatments for back issues without success for at least six months may be suitable candidates for this trial.
As an unphased study, this trial provides a unique opportunity to contribute to advancements in spinal surgery.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on medications that interfere with bone or soft tissue healing, like certain steroids or immunosuppressives.
What prior data suggests that these spinal cages are safe for lumbar fusion procedures?
Research has shown that both the Medtronic Adaptix™ titanium implants and the Medtronic CAPSTONE® PEEK cage have safety information available.
For the Adaptix™ titanium implants, possible risks include the implant moving out of place, breaking, and the body reacting against the implant. These risks are common with many implants, but awareness is important.
PEEK cages, such as those in the CAPSTONE® system, are often used in spinal surgeries. Some studies suggest they might not fuse as quickly as titanium-coated options. However, they have been used for a long time, and many patients have experienced good results.
Both treatments have undergone safety studies, and while risks exist, many patients have had positive experiences. Always consult your doctor to determine if these options are suitable for you.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments because they offer innovative approaches to spinal fusion, a common procedure for treating spinal conditions. The Medtronic Adaptix™ titanium implants are notable for their robust strength and potential for better integration with bone due to the titanium's biocompatibility. In contrast, the Medtronic CAPSTONE® PEEK cage is made of a polymer that offers flexibility and radiolucency, allowing for easier monitoring of the bone healing process through imaging. Both treatments are used in conjunction with a mix of autograft and allograft bone, avoiding the need for additional bone harvesting from the patient's iliac crest, which can reduce patient discomfort and recovery time. These features make the treatments promising alternatives to traditional spinal fusion methods, which often rely on iliac crest autografts and metal cages.
What evidence suggests that this trial's treatments could be effective for spinal conditions?
This trial will compare Medtronic Adaptix™ titanium implants with Medtronic CAPSTONE® PEEK cages for spinal fusion surgeries. Research has shown that titanium implants, like the Adaptix, bond well with bone, potentially speeding up healing and reducing complications. Meanwhile, the CAPSTONE® PEEK cages have demonstrated effectiveness in aiding bone fusion and improving spine alignment in some patients. Specifically, a study of patients with neck spine issues found that PEEK cages helped maintain disc space and spine angle stability. Both treatments hold promise, but success can vary based on individual patient factors.23678
Are You a Good Fit for This Trial?
Adults over 18 needing lumbar fusion surgery for conditions like spondylolisthesis or degenerative disc disease, who've had no relief from 6 months of conservative care. Excludes those with prior lumbar surgery, certain medical conditions, obesity (BMI >45), infections, metal sensitivities, substance abuse history, pregnancy/lactation plans within a year, and involvement in litigation or other studies.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo lumbar fusion surgery using either Medtronic Adaptix™ titanium implants or CAPSTONE® PEEK cages, supplemented with a pedicle screw system and a 50:50 mixture of autograft: allograft.
Follow-up
Participants are monitored for clinical and radiographic outcomes, with assessments at 3, 6, 12, and 24 months post-surgery.
What Are the Treatments Tested in This Trial?
Interventions
- Medtronic Adaptix™ titanium implants
- Medtronic CAPSTONE® PEEK cage
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor